SCHEMBL476911

SCHEMBL476911

CC(=Cc1ccccc1)C(N)=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.69
MCL1 Q07820 1/20 0.53
ALDH1A1 P00352 2/20 0.52
TSHR P16473 1/20 0.52
HTT P42858 1/20 0.52
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
DHODH Q02127 1/20 0.49
TRPM8 Q7Z2W7 1/20 0.49
SLC9A1 P19634 1/20 0.49
SLC9A3 P48764 1/20 0.49
SLC9A2 Q9UBY0 1/20 0.49
RECQL P46063 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
FBP1 P09467 2/20 0.47
GLA P06280 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL554744 1.00 AKR1C3 (0.69) AKR1C3MCL1ALDH1A1TSHRHTT
Phenol SCHEMBL29181787 0.92 AKR1C3 (0.60) AKR1C3MCL1ALDH1A1TSHRHTT
SCHEMBL5830527 0.89 AKR1C3 (0.52) AKR1C3MCL1ALDH1A1HTTNPC1
SCHEMBL5830531 0.89 AKR1C3 (0.52) AKR1C3MCL1ALDH1A1HTTNPC1
SCHEMBL378903 0.84 MAPT (0.51) AKR1C3ALDH1A1TSHRHTTNPC1
SCHEMBL4622685 0.84 MAPT (0.51) AKR1C3ALDH1A1TSHRHTTNPC1
SCHEMBL29158024 0.84 TBXAS1 (0.56) AKR1C3MCL1ALDH1A1NPC1RAB9A
SCHEMBL805622 0.82 AKR1C3 (0.75) AKR1C3ALDH1A1TSHRHTTNPC1
SCHEMBL759655 0.82 AKR1C3 (0.75) AKR1C3ALDH1A1TSHRHTTNPC1
SCHEMBL759656 0.82 AKR1C3 (0.75) AKR1C3ALDH1A1TSHRHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 960 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260040695-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER NEWSOUTH INNOVATIONS PTY LTD (AU) 2026-02-05 US claimed
US-20250198980-A1 COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2025-06-19 US claimed
EP-4562077-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER NewSouth Innovations Pty Limited (AU) 2025-06-04 EP claimed
US-12135503-B2 Organometallic photoresists for DUV or EUV lithography INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2024-11-05 US claimed
WO-2024020649-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2024-02-01 WO claimed
WO-2022261721-A1 HEALABLE AND REPROCESSABLE COMPOSITIONS DEAKIN UNIVERSITY (AU) 2022-12-22 WO claimed
US-20220317572-A1 ORGANOMETALLIC PHOTORESISTS FOR DUV OR EUV LITHOGRAPHY INTERNATIONAL BUSINESS MACHINES CORPORATION 2022-10-06 US claimed
EP-3735439-A1 STABLE ORGANIC LIGHT EMITTING COATING Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) 2020-11-11 EP claimed
WO-2019135223-A1 STABLE ORGANIC LIGHT EMITTING COATING YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2019-07-11 WO claimed
CN-106543148-B A kind of substitution Oxoindole-benzimidazole salt compound and preparation method thereof 云南大学 2019-04-16 CN claimed
WO-2004041232-A1 PERFUME POLYMERIC PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2004-05-21 WO claimed
US-20030134977-A1 High refractive index aromatic-based prepolymers PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.) (PL) 2003-07-17 US claimed
US-20030130465-A1 High refractive index aromatic-based prepolymer precursors BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED) (IE) 2003-07-10 US claimed
WO-2003040200-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED PREPOLYMERS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed
WO-2003040214-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED PREPOLYMER PRECURSORS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO claimed
EP-1294707-A2 THIOPHENE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2003-03-26 EP claimed
WO-2001098290-A2 THIOPHENE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2001-12-27 WO claimed
WO-2000034804-A1 HIGH REFRACTIVE INDEX HYDROGEL COMPOSITIONS FOR OPHTHALMIC IMPLANTS BAUSCH & LOMB SURGICAL, INC. (US) 2000-06-15 WO claimed
US-5549807-A Thermoplastic composites formed by electropolymerization of N-substituted methacrylamide monomers THE UNIVERSITY OF CONNECTICUT (US) 1996-08-27 US claimed
US-5238542-A Onto electrically conductive filler THE UNIVERSITY OF CONNECTICUT (US) 1993-08-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134977-A1 High refractive index aromatic-based prepolymers FHIT, PLOD3, AHR AKR1C3 2057/4885MCL1 4781/4885ALDH1A1 1690/4885
US-20260040695-A1 A METHOD TO GENERATE CONDUCTIVE POLYMER PIEZO1, LCP1, MTCL3 AKR1C3 4848/4885MCL1 2852/4885ALDH1A1 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.